Barrington analyst Kevin Steinke maintained an Outperform rating on Cimpress, saying the market opportunity in the name was still intact, but the analyst lowered his price target on shares to $100 from $135 after weaker than expected Q2 revenues and reduced Vistaprint revenue growth outlook. He views Vistaprint's reduced outlook as "largely a conscious management decision to slow growth while operational issues are addressed" and is "encouraged by continued sales growth for small business products, indicating that demand remains solid." After Thursday's 28% pullback, Steinke sees Cimpress as attractive for patient investors.